JAK2 and acquired polycythemia vera: For PV diagnosis, most HCPs reported using serum erythropoietin (EPO) level (44/57, 77%), alongside an FBC (49/57, 86%) and peripheral blood JAK2 V617F mutational analysis (49/57, 86%).